These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2315913)

  • 1. Evaluation of a two-drug combination pretreatment against organophosphorus exposure.
    Solana RP; Harris LW; Carter WH; Talbot BG; Carchman RA; Gennings C
    Toxicol Appl Pharmacol; 1990 Mar; 102(3):421-9. PubMed ID: 2315913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the efficacy of azaprophen and physostigmine as a pretreatment for soman-induced incapacitation in guinea pigs by response-surface modeling.
    Gennings C; Carter WH; Harris LW; Carchman RA; Campbell ED; Boyle RM; Talbot BG; Solana RP
    Fundam Appl Toxicol; 1990 Feb; 14(2):235-42. PubMed ID: 2318349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
    Harris LW; Talbot BG; Lennox WJ; Anderson DR; Solana RP
    Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
    Wetherell JR
    J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful pretreatment/therapy of soman, sarin and VX intoxication.
    Lennox WJ; Harris LW; Anderson DR; Solana RP; Murrow ML; Wade JV
    Drug Chem Toxicol; 1992; 15(4):271-83. PubMed ID: 1459040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication.
    von Bredow J; Corcoran K; Maitland G; Kaminskis A; Adams N; Wade J
    Fundam Appl Toxicol; 1991 Nov; 17(4):782-9. PubMed ID: 1778364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
    Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
    Philippens IH; Vanwersch RA; Groen B; Olivier B; Bruijnzeel PL; Melchers BP
    Toxicol Sci; 2000 Jan; 53(1):84-91. PubMed ID: 10653525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by soman.
    Harris LW; Anderson DR; Pastelak AM; Vanderpool B
    Drug Chem Toxicol; 1990; 13(2-3):241-8. PubMed ID: 2276342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs.
    Philippens IH; Melchers BP; Olivier B; Bruijnzeel PL
    Pharmacol Biochem Behav; 2000 Jan; 65(1):175-82. PubMed ID: 10638651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
    Cho Y; Kim WS; Hur GH; Ha YC
    Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects.
    Philippens IH; Busker RW; Wolthuis OL; Olivier B; Bruijnzeel PL; Melchers BP
    Pharmacol Biochem Behav; 1998 Apr; 59(4):1061-7. PubMed ID: 9586868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs.
    Meshulam Y; Davidovici R; Wengier A; Levy A
    J Appl Toxicol; 1995; 15(4):263-6. PubMed ID: 7594194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus).
    Muggleton NG; Bowditch AP; Crofts HS; Scott EA; Pearce PC
    Psychopharmacology (Berl); 2003 Mar; 166(3):212-20. PubMed ID: 12589520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trihexyphenidyl enhances physostigmine prophylaxis against soman poisoning in guinea pigs.
    Lim DK; Hoskins B; Ho IK
    Fundam Appl Toxicol; 1991 Apr; 16(3):482-9. PubMed ID: 1855620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro.
    Herkert NM; Schulz S; Wille T; Thiermann H; Hatz RA; Worek F
    Toxicol Appl Pharmacol; 2011 May; 253(1):7-13. PubMed ID: 21402092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
    Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
    Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
    Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
    Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.